| abstract |
[Problems] Prolyl hydroxylase-mediated anemia, hypoxia, ischemia, peripheral vascular disease, myocardial infarction, stroke, diabetes, obesity, inflammatory bowel disease, ulcerative colitis, Crohn's disease, wound, infection Providing compounds for treating burns and fractures. Benzimidazole compounds exemplified by the following formula, and enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts thereof. [Selection figure] None |